Kamrani Amin, Hosseinzadeh Ramin, Shomali Navid, Heris Javad Ahmadian, Shahabi Parviz, Mohammadinasab Reza, Sadeghvand Shahram, Ghahremanzadeh Kazem, Sadeghi Mohammadreza, Akbari Morteza
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran.
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Pathol Res Pract. 2023 Aug;248:154632. doi: 10.1016/j.prp.2023.154632. Epub 2023 Jun 19.
Neoplasms are a worldwide recognized non-contagious disease which has the most mortality rate after cardiovascular diseases. For decades, there has been a vast amount of study on treatment methods of cancer which has led to conventional therapies such as chemotherapy, radiation therapy, surgery and so on. Clinicians and researchers believed that there is an urgent need, considering the high rate of incidence and prevalence, for an alternative treatment option which is more efficacious and has less adverse effects than the above-mentioned treatments. Immunotherapy has emerged as a potential treatment alternative in a few years and became one of the fastest developing therapeutic approaches. Different kinds of immunotherapies are FDA approved and available for treatment of various cancer types. In this review, we have summarized the major immunotherapy methods including checkpoint inhibitors, CAR T cell therapies and cancer vaccines. Furthermore, application of combination therapy, precision medicine, biomarker discovery, overcoming resistance and reduction of adverse effects are discussed in this study.
肿瘤是一种全球公认的非传染性疾病,其死亡率在心血管疾病之后位居第二。几十年来,人们对癌症治疗方法进行了大量研究,从而产生了化疗、放疗、手术等传统疗法。临床医生和研究人员认为,鉴于癌症的高发病率和高患病率,迫切需要一种比上述治疗方法更有效且副作用更小的替代治疗方案。免疫疗法在几年内已成为一种潜在的治疗选择,并成为发展最快的治疗方法之一。不同类型的免疫疗法已获得美国食品药品监督管理局(FDA)批准,可用于治疗各种癌症类型。在本综述中,我们总结了主要的免疫疗法,包括检查点抑制剂、嵌合抗原受体(CAR)T细胞疗法和癌症疫苗。此外,本研究还讨论了联合疗法的应用、精准医学、生物标志物发现、克服耐药性以及减少副作用等问题。